Association of ITPA polymorphism with outcomes of peginterferon-&alpha; plus ribavirin combination therapy

doi:10.4292/wjgpt.v4.i3.54

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5111)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

404

HTML

2183

Figures (1-1)

219

Tables (1-5)

226

Sum=3032

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1026

Download

1053

Sum=2079

Aug 6, 2013 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. Aug 6, 2013; 4(3): 54-60
Published online Aug 6, 2013. doi: 10.4292/wjgpt.v4.i3.54

Table 3 Virological response according to classification by inosine triphosphatase and interleukin 28B single-nucleotide polymorphisms n (%)

Virological response	IL28B: TT		IL28B: TG + GG
Virological response	CA + AA (n = 29)¹	CC (n = 53)¹	CA + AA (n = 8)¹	CC (n = 30)¹
RVR	3 (10.3)	10 (18.9)	0 (0.0)	4 (13.3)
RVR + EVR	18 (62.1)	35 (66.0)	1 (12.5)	8 (26.6)
SVR	13 (44.8)	29 (54.7)	2 (25.0)	8 (26.6)

¹Inosine triphosphatase (ITPA). SVR: Sustained virological response; RVR: Rapid virological response; EVR: Early virological response; IL28B: Interleukin 28B.

Citation: Fujino T, Aoyagi Y, Takahashi M, Yada R, Yamamoto N, Ohishi Y, Nishiura A, Kohjima M, Yoshimoto T, Fukuizumi K, Nakashima M, Kato M, Kotoh K, Nakamuta M, Enjoji M. Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy. World J Gastrointest Pharmacol Ther 2013; 4(3): 54-60
URL: https://www.wjgnet.com/2150-5349/full/v4/i3/54.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v4.i3.54